Loading organizations...
Key people at Newton Biocapital.
Key people at Newton Biocapital.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Dec 10, 2025 | Bioxodes | $6.4M Series A Extension | Alain Parthoens | — |
| Sep 1, 2023 | AbolerIS Pharma | $29.0M Series A | Caixa Capital | BioVentures Investors, Sambrinvest, SFPI-FPIM, Sound Bioventures, Sudinvest, Turenne Capital, Wallonie Entreprendre |
| Jun 7, 2023 | Santero Therapeutics | $8.6M Series A | Philippe De Backer, Newton Biocapital | Sambrinvest, SFPI-FPIM, Wallonie Entreprendre |
| Jan 19, 2023 | DeuterOncology | $6.1M Series A | InvestSud, Newton Biocapital, Noshaq | — |
| Jan 18, 2023 | Synergia Medical | $4.1M Series B Extension | — | Jacques Berrebi, Invest.BW, InvestSud, SFPI, SRIW, TheClubDeal |
| Nov 1, 2019 | Acticor Biotech | $8.0M Series B | Go Capital | Karista, Anaxago |
| Oct 1, 2018 | Acticor Biotech | $18.0M Series B | Alain Parthoens | Karista, AB Ventures, Cukierman Life Sciences, Hyun Tae Kim |
| Feb 19, 2018 | Synergia Medical | $10.1M Series A | Alain Parthoens | Pierre Detrixhe, SFPI-FPIM, SRIW |